InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (6 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
6
T+90 hit rate
100%
T+90 mean return
+12.1%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Greenleaf Peter, Director. Director active across 4 companies, notably Pelthos Therapeutics Inc.. Cumulatively, 20 filings have been published. Split: 1 buy · 6 sells. Total volume traded: €977k. Activity tracked since 11 May 2021. The latest transaction was disclosed on 2 July 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Greenleaf Peter
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations20 total
712 shares@ US$25.99540.021% mcap88.9% of flowCommon StockSEC:0001919246-26-000100:0
85 shares@ US$27.27330.0026% mcap11.1% of flowCommon StockSEC:0001919246-26-000100:1
420 shares@ US$20.515122.8% of flowCommon StockSEC:0001919246-26-000052:0
377 shares@ US$21.361421.4% of flowCommon StockSEC:0001919246-26-000052:1
25,478 shares0Common StockSEC:0001919246-26-000043:0
196,403 shares0Common StockSEC:0001600620-26-000021:0
100,171 shares@ US$14.4056.5% of flowCommon StockSEC:0001363683-26-000002:0
165,384 shares0Common StockSEC:0001600620-26-000002:0
290,728 shares0Common StockSEC:0001600620-25-000024:0
126,981 shares@ US$5.6068.0% of flowCommon StockSEC:0001600620-24-000038:0
661,538 shares0Common StockSEC:0001600620-24-000017:0
33,047 shares@ US$8.7828.3% of flowCommon StockSEC:0001600620-24-000013:0
667,407 sharesCommon StockSEC:0001628280-23-006526:0
30,220 shares@ US$5.6046.0% of flowCommon StockSEC:0000899243-22-019780:0
105,034 shares0Common StockSEC:0001103021-22-000067:0
28,300 shares0Common StockSEC:0001628280-22-005123:0
10,246 shares0Common StockSEC:0001103021-22-000021:0
35,000 shares0Common StockSEC:0001103021-21-000070:0
25,452 shares@ US$4.4237.0% of flowCommon StockSEC:0001209191-21-040329:0
2,133 shares@ US$10.150.8% of flowCommon StockSEC:0001628280-21-010022:0
Canonical exit: 9 Aug 2021 (T+90)
20 of 20 declarations
About Greenleaf Peter
Peter Greenleaf is a Director and Chief Executive Officer of Pelthos Therapeutics Inc., Aurinia Pharmaceuticals Inc., and ANTARES PHARMA, INC. He leads these companies with a focus on innovation and the development of new treatments.
